LCA168 for Glioblastoma?
Glioblastoma is a dangerous brain tumor known for its rapid growth and unresponsiveness to typical treatments. Studies are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential focus here for glioblastoma treatment. LCA168 is a protein that is overexpressed in GBM cells com